We are Antioxidant 618 CAS:3806-34-6 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
SPECIFICATIONS AND PHYSICAL CHARACTERISTICS
PRODUCT FEATURES AND APPLICATIONS
* AN 618 is a new type of phosphite antioxidant with excellent performance.With high phosphorus, it has strong ability to decompose hydroperoxide and excellent initial color.It can be used in food packaging materials, replacing antioxidant BHT and auxiliary antioxidant DLTDP
* AN 618 is mainly used for polyethylene, polystyrene, polypropylene, ABS resin, EVA copolymer, polyvinyl chloride and polycarbonate.
* AN 618 is often used together with hindered phenolic antioxidants or hindered amine light stabilizers to synergistic effects. The dosage is 0.3%-0.5%
*As thermal resistant antioxidant , AN 618 is often used in combination with hindered phenolic antioxidants, for ABS, PS, HIPS, NBR, SBS, PP, PE, LLDPE, PVC, PC, PA, PET, PU,polyamide fiber, Polyester fiber, paint, ink or compounds of metal heat stabilizer.
*Due to the diphosphite structure,it has high level trivalent phosphorus and effective anti-aging performance.
HANDLING AND STORAGE
Keep container tightly closed and dry and storage in cool place
Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.N-(2-(4-(1H-benzo[d]imidazol-2-yl)piperazin-1-yl)ethyl)-4-bromo-2-ethyl-N-methylbenzenesulfonamide There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.1,3-Dibromo-2,2-dimethoxypropane CAS:22094-18-4 The workers are demanding that Hong Kong close all border checkpoints to visitors from mainland China, saying they represent a threat to health care workers in the city.4-(5β-cholestan-3-ylidenehydrazino)-benzoic acid In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.